National Hospital, Kyoto, Japan Abstract In order to investigate the effect of 3, 5, 3'L-triiodothyronine (T3) administration on thyroid hormone concentrations in serum, thyroxine (T4), T3, 3, 3', 5'L-triiodothyronine (reverse T3, rT3) and thyroid stimulating hormone (TSH) concentrations in serum were determined before and after T3 administration in 10 hypothyroid patients maintained on constant doses of T4.
Ten hypothyroid patients given 100 ig of T4 for approximately 3 months had almost normal T4 and T3 concentrations in serum. Seven patients showed almost normal rT3 concentrations in serum and they were slightly diminished in the remaining 3 patients.
TSH levels in serum were almost within the normal limit in 7 out of 10 patients.
However, despite the elevation of T4 and T3 levels, 3 patients had markedly elevated TSH levels.
Values for serum T4 concentrations were decreased 4 weeks after the administration of 50 ig T3 in all patients maintained on constant doses of T4, although they were almost within the normal range. T3 concentrations in serum, which was obtained just before the administration of the next daily doses of T3, were markedly elevated in 6 of 10 patients after T3 administration and the remaining 4 patients had also slightly higher T3 concentrations than those before T3 administration. On the other hand, serum rT3 concentrations were diminished in 5 patients during T3 ingestion.
They were somewhat diminished or almost unchanged before and after T3 administration in the remaining 5 patients. Moreover, 3 patients with elevated TSH levels during T4 administration showed almost normal TSH levels after T4 and T3 ingestion.
The results showed the reciprocal relationship between T3 and rT3 levels in serum after T3 administration in hypothyroid patients maintained on constant doses of T4. Furthermore, the present findings suggest that the administration of both T4 and T3 might be a more suitable replacement therapy in the patients with hypothyroidism than T4 alone.
It has been reported that the protein bound iodine (PBI) was decreased after 3, 5, 3'L-triiodothyronine (T3) administration in hypothyroid patients maintained on the constant doses of thyroxine (T4) (Farmer et al., 1969) . However, the changes in serum T3 and 3, 3', 5'L-triiodothyronine (reverse T3, rT3) after T3 administration have not been observed in detail.
In the present study, the effect of T3 administration on serum T4, T3, rT3 and thyroid stimulating hormone (TSH) concentrations was investigated in hypothyroid patients treated with constant doses of T4. Finally, the elevated TSH levels observed in 3 patients during T4 administration were decreased almost to the normal range after both T4 and T3 administration (Table 1) .
Discussion
In the present paper, serum T4 concentrations were diminished after T3 administration in hypothyroid patients maintained on constant doses of T4, although they were still within the normal range. The results were consistent with those obtained by Farmer et al. (1969) . On the other hand, serum T3 concentrations were elevated after T3 administration in patients maintained on constant doses of T4. Previous studies (Surks et al., 1972; Saberi and Utiger, 1974) have shown that serum T3 concentrations were increased transiently within the first 1-8 hrs after ingestion of both T4 and T3, and returned to the initial value about 24 hr after ingestion. In order to minimize the influence of ingested T3 on serum T3 concentrations, serum were obtained just before the administration of the next daily dose in the present study. A recent study (Chiraseveenuprapund et al., 1978) , which investigated the conversion of T4 to T3 in rat kidney homogenate, has demonstrated that the addition of varying amounts of T3 into the homogenate incubated with T4 did not appreciably affect the rate of T3 formation.
They suggested that there was little inhibition of T4 monodeiodination by the product T3. Moreover, Grussendorf and Hilfner (Grussendorf and Hiifner, 1977) found that L-T3 and D-T3 very effectively increased the T4 to T3 converting activity of liver homogenate in thyroidectomized rat. Therefore, the elevation of the serum T3 concentration after T3 administration in the present paper might be partly due to an increase in T3 production by the elevated conversion rate.
Recently, the determinations of rT3 concentrations in serum by radioimmunoassay and the turnover studies of radioactive rT3 have been made by several investigators (Chopra, 1974; Chopra, 1976; Burman et al., 1977; Gavin et al., 1977) . They showed that rT3 as well as T3 was a major product of T4 monodeiodination and that a small proportion of rT3 production arose directly from the thyroid. Thus, the majority of T4 metabolized daily was monodeiodinated either to T3 or to rT3 and, therefore, the monodeiodination was an essential step in T4 metabolism. It has been reported that the serum rT3 concentration was increased in situations where serum T3 was decreased (Chopra, 1974) . These findings suggested that the 5"-monodeiodination of T4 was inhibited, resulting in the inhibition of T3 formation and of rT3 degradation (Kaplan and Utiger, 1978) . In the present paper, serum rT3 concentrations tended to diminish after T3 administration in hypothyroid patients maintained on constant doses of T4, while serum T3 concentrations were elevated in these patients. The results suggest a reciprocal relationship between serum T3 concentrations and rT3 concentrations after T3 administration in the patients maintained on constant doses of T4. Thus, it seemed likely from the present findings that 5"-monodeiodination of T4 may be stimulated by T3, causing an elevation in the rate of T4 to T3 conversion and of rT3 degradation.
Since the previous study (Braverman et al., 1970) of athyreotic patients receiving L-T4 therapy revealed normal or increased concentrations of serum T3, because of the peripheral T4 to T3 conversion, it was well known that L-T4 was a suitable agent in hormonal replacement therapy of patients with hypothyroidism (Stock et al., 1974; Braverman et al., 1973) . In the present study, serum T3 concentrations were elevated to the normal range after T4 administration in hypothyroid patients. The results were consistent with those obtained by the previous study (Braverman et al., 1970) . However, in the present study, it was noteworthy that 3 of 10 patients had still elevated TSH concentrations in serum, despite the administration of T4 for approximately 3 months, although the doses were slightly less than the dosis (2.25 pg/kg body weight) recommended by the previous report (Stock et al., 1974) . It has been suggested that adequate replacement therapy with L-T4 would require doses sufficient to establish values for a serum T4 concentration above the normol range (Sturnick and Lesses, 1961; Lavietes and Epstein, 1964) . Moreover, the amount of T3 generated by the conversion of T4 to T3 was found to contribute to approximately 70% of the daily T3 production in normal subjects and, therefore, the 30% of the T3 production was assumed to be secreted directly from the thyroid (Inada et al., 1975) . In the present paper, the elevated TSH levels found in 3 patients after T4 administration were reduced to the normal range within 4 weeks after T4 and T3 administration. The present findings suggest that the administration of both T4 and T3 together might be more a suitable replacement therapy for patients with hypothyroidism than T4 alone.
